Bottom Line: Ellis achieves the right chemistry
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.FRESH management at Ellis & Everard, the commodity chemicals distributor, has resurrected the company's reputation in the City after a period of ill-judged expansion into specialist chemicals sent its shares and profits into a downward spiral.
Its results for the six months to 31 October provide evidence of rehabilitation at work. Back concentrating on what it knows best, Ellis's pre-tax profits rose 30 per cent to pounds 8.5m and the dividend has been lifted by 9 per cent to 2.45p.
Ellis benefited from a bit of everything during the period: currencies added pounds 500,000, sales picked up, prices held and a tight rein was kept on costs.
Shares rose 4p to 241p. Assuming the group makes full-year taxable profits of pounds 16m, the stock is trading on a prospective earnings multiple of 18 - some way above the sector average that is itself some way ahead of the market as a whole.
The prospective yield of 4 per cent accounts for some of the high rating. The company has also gained followers now that its profit base appears more reliable. There are obvious attractions in cyclical chemicals stocks as well - exposed to the US and the UK, Ellis can reasonably expect some help from reviving economies.
However, the shares are also being supported by hopes that commodity chemical prices, currently near an historical low, will inevitably increase. This would help Ellis because it earns its money in proportion to chemical selling prices. The higher the price, the bigger Ellis's cut.
Chemical prices are depressed because too much production is chasing too little demand. In time prices may rise.
But the experience of steel and bread producers - both also plagued by over-capacity - suggests the wait may be long and the results not entirely satisfying. Patience is required with Ellis shares but the yield is a compensation.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments